PROCERTUS BIOPHARM
ProCertus BioPharm, Inc., an oncology-based pharmaceutical company, develops therapeutics to protect cancer patients from the side effects of radiotherapy and chemotherapy in the United States. Its products include ProDermaCel that protects cancer patients from chemotherapy- and radiotherapy-induced alopecia; DermX, which prevents radiotherapy-induced dermatitis; and OralX that provides protection against chemotherapy- and radiotherapy- induced oral mucositis. ProCertus BioPharm, Inc. was founded in 1997 and is based in Madison, Wisconsin.
PROCERTUS BIOPHARM
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
1997-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.procertus.com
Total Employee:
1+
Status:
Closed
Contact:
16082778041
Email Addresses:
[email protected]
Total Funding:
6.17 M USD
Technology used in webpage:
SPF Amazon Amazon Frankfurt Region
Current Advisors List
Current Employees Featured
Founder
Investors List
Novartis Venture Fund
Novartis Venture Fund investment in Series A - ProCertus BioPharm
Venture Investors
Venture Investors investment in Venture Round - ProCertus BioPharm
Novartis Venture Fund
Novartis Venture Fund investment in Venture Round - ProCertus BioPharm
Novartis Venture Fund
Novartis Venture Fund investment in Series A - ProCertus BioPharm
Venture Investors
Venture Investors investment in Series A - ProCertus BioPharm
Official Site Inspections
http://www.procertus.com
- Host name: redirect.ovh.net
- IP address: 213.186.33.5
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
